Cite

HARVARD Citation

    Golan, T. et al. (2018). LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial. Journal of cachexia, sarcopenia and muscle. 9 (5), pp. 871-879. [Online]. 
  
Back to record